Home › Funds › NEA Management Company, LLC › ZBIO

NEA Management Company, LLC position in ZBIO

ZENAS BIOPHARMA INC COM · Health Care

NEA Management Company, LLC reported holding 4,023,219 shares of ZBIO (ZENAS BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$102.1M, representing 6.43% of its reported portfolio and ranking #7 among its reported holdings. NEA Management Company, LLC has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)4.02M sh
Reported value held$102.11M
Portfolio Weight6.43%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NEA Management Company, LLC's ZBIO position evolved

NEA Management Company, LLC first disclosed a stake in ZBIO in Q3 2024 at 2,613,948 shares (US$44.2M). The position peaked in Q4 2025 at 3,523,219 shares, worth US$127.9M. Across 8 filings, NEA Management Company, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 4,023,219 shares valued at US$102.1M. Notable position changes include a 29% increase in Q4 2025 (shares fell 46% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.61M $44.23M New
Q4 2024 2.61M $21.41M Hold
Q1 2025 2.61M $20.65M Hold
Q2 2025 2.73M $26.49M Add
Q3 2025 2.73M $60.69M Hold
Q4 2025 3.52M $127.93M Add
Q1 2026 4.02M $78.65M Add
Q2 2026 4.02M $102.11M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBIO and 13F data

ZBIO (ZENAS BIOPHARMA INC COM) is a Health Care company. 68 other funds we track also report a position in ZBIO — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$127.9M), Enavate Sciences GP, LLC (US$99.5M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$80.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBIO

All ZBIO fund holders →

FAQ

How long has NEA Management Company, LLC held ZBIO?

NEA Management Company, LLC has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is NEA Management Company, LLC's current position in ZBIO?

As of Q2 2026, NEA Management Company, LLC holds 4.02M shares of ZBIO (ZENAS BIOPHARMA INC COM), valued at $102.11M, representing 6.43% of its reported portfolio and ranking #7.

Has NEA Management Company, LLC been buying or selling ZBIO?

In the latest 13F filing (Q2 2026), NEA Management Company, LLC held unchanged its position in ZBIO. The position peaked in Q4 2025 at 3.52M shares.

Which other funds hold ZBIO?

Other major institutional holders of ZBIO include SR ONE CAPITAL MANAGEMENT, LP, Enavate Sciences GP, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.